New Zealand invades Chicago's BIO 2006

9 April 2006

Over 40 New Zealand companies and research institutions will attend the BIO 2006 international conference in Chicago, USA, as part of a delegation led by the country's Ambassador to the USA, Roy Ferguson, April 9-12 at Chicago's McCormick Place Convention Center. Boasting top-ranking in the World Bank's December 2005 ratings as the best country in which to do business, the New Zealand's trade and enterprise promotion body is making a big push for the country to obtain partnerships with leading USA-based and other international companies and research institutions.

Chris Boalch, director of biotechnology at New Zealand Trade and Enterprise, said: "the country's global mindset is illustrated by the diverse range of connections between New Zealand scientists, companies and the international biotechnology industry, including strong, growing ties to the US midwest."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight